Introduction
Although complete remissions are nowadays obtained in the majority of patients with acute lymphoblastic leukemia (ALL), a significant proportion -depending mainly on pretherapeutic risk-factors -relapse and die of their disease. 1 Several studies showed that quantitative measurement of MRD is useful as an independent risk factor for individual patients in ALL. Polymerase chain reaction (PCR) is the most sensitive and widely applicable method for MRD detection. [2] [3] [4] [5] [6] [7] IgH gene rearrangements can be used as molecular targets for tumor-specific detection of MRD in about 90% of B-lineage ALL 1, 7 and in approximately 80% of lymphoma and myeloma patients. 8 Traditional quantitative PCR assays usually rely on end point data collection resulting in PCR inherent quantitating problems as broad standard deviations of final PCR product amounts. 2, 9, 10 As a result, the quantitative potential of these tests is limited. RQ PCR applying TaqMan technology is a new method for quantitative assessment of MRD. 9, [11] [12] [13] [14] This technique uses an oligonucleotide hybridization probe in combination with standard amplification primers. The probe positioned internally to the PCR primers is labelled with a reporter fluorescent dye at the 5Ј end and a quenching dye at the 3Ј end. While fluorescence of the intact probe is quenched, 5Ј-3Ј nuclease activity of the polymerase leads to separation of the dyes during amplification by degradation of the probe which results in an increase of reporter dye fluorescence intensity. The quantitative amount of PCR products is continuously ('real-time') monitored during the cycles allowing the rapid quantitation over several orders of magnitude without need for post-PCR processing. [15] [16] [17] However, a major disadvantage of the published RQ PCR assays using gene rearrangements as clonal markers for MRD is the utilization of specific TaqMan probes for every individual patient. 9, 13 Clone-specific TaqMan probes are not only expensive but also time-consuming to design and to test which limits their applicability in clinical settings. In addition, when used in combination with consensus primers sensitivity of RQ PCR compared to traditional quantitative PCR assays seems to be reduced. 13 The present work was done to overcome these limitations by creating probes and downstream primers to consensus regions of the IgH gene joining (J H ) elements that are suitable for the majority of IgH gene rearrangements. In combination with upstream ASO primers spanning the unique marker sequence of the IgH-CDR3 regions consensus germline J H primers and probes were tested for their applicability to RQ PCR MRD assays. The method was evaluated on DNA extracts of 22 patients with B-lineage ALL with a PCR amplifiable IgH rearrangement. We compared the sensitivity of this new approach with a RQ PCR technique utilizing patient-specific probes. It is shown that the new assay can accurately quantitate residual leukemia with a detection limit of one leukemia cell per 10 4 to 10 5 normal cells. The usefulness of the established RQ PCR assay for assessment of MRD was demonstrated on follow-up samples of six patients.
Materials and methods

Clinical samples
Diagnostic DNA samples from 22 patients with B-lineage ALL were selected for this study. In addition, two to five followup samples of cases 1-6 were investigated for quantitative MRD. All patients were participants in the German Multicenter ALL-Study Group and were enrolled in the study between 1988 and 1998. Type of ALL was determined by immunophenotyping and morphology in all cases. Mononuclear cells (MNC) were isolated from all samples and stored at −70°C before DNA extraction. Pooled MNC-DNA from equivalent amounts of five healthy donors served as polyclonal control.
DNA was isolated by standard procedures using an DNA isolation kit (Boehringer Mannheim, Mannheim, Germany), and quantified by luminescence spectrometer analysis (Biotech Ultraspec 3000, Pharmacia, Cambridge, UK).
IgH-CDR3 consensus PCR and fluorescent fragment analysis
The standard PCR assay with consensus V H and J H primers used for identification of monoclonal IgH-CDR3 rearrangements followed a previously described protocol. 18 The reaction tubes for PCR contained 0.5 g of genomic DNA, 5 pmol of each primer, 2 units of UItma DNA polymerase (PE Biosystems, Foster City, CA, USA) and 80 M of each deoxyribonucleotide in a final volume of 30 l reaction buffer. PCR was performed for 35 cycles in a Model 9600 thermal cycler (PE Biosystems). Cycle conditions were: denaturation at 96°C for 1 min and annealing/extension at 55°C for 45 s with extension of the first denaturation step to 7 min and a final primer elongation step of 10 min at 70°C. PCR was hot start initiated by adding BioWax (Biozym, Hameln, Germany) to the reaction tubes. The V H primer was labelled at its 5Ј end with 6Ј FAM (6-carboxyfluorescein) (PE Biosystems) for automated fluorescent fragment analysis (genescanning) of the generated PCR products. Reaction products were analyzed on an ABI PRISM 377 (PE Biosystems) by exact size determination and quantitative measurement of fluorescence intensity with the genescan software (PE Biosystems) after electrophoresis on a high resolution polyacrylamide gel. PCR products with a dominant monoclonal genescanning pattern were sequenced directly using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystems) on the ABI PRISM 377 automated sequencer (for details see Ref. 19) . 19 Monoclonal PCR products with significant background bands were sequenced after cloning. 20 J H elements and individual D H segments were identified by comparison with published germline sequences. [21] [22] [23] [24] [25] [26] 
RQ PCR primers and probes
Oligonucleotide design for ASO probe RQ PCR approach:
Clone-specific TaqMan probes complementary to CDR3 (N-D H -N) sequences of six patients (cases 1-6) were designed in combination with upstream V H -N (or V H -N-D H ) and downstream germline J H primers using Primer Express software (PE Biosystems).
Oligonucleotide design for consensus probe RQ PCR approach:
Two different consensus J H probes (J H Q 1/4/5 and J H Q 6 ) were designed using published germline J H sequences (Table 1) . 21, 22 These two probes span areas with the highest degree of homology among different J H gene families and fit to around 90% of all known J H rearrangements. 27 J H Q 1/4/5 fits to the J H 1, J H 4 and J H 5 family, J H Q 6 to the J H 6 family. All probes were labelled at the 5Ј-end with a reporter dye (FAM = 6-carboxyfluorescein), at the 3Ј-end with a quencher dye (TAMRA = 6-carboxytetramethylrhodamine) and phosphorylated at the 3Ј-end to prevent extension during PCR.
For each J H family one reverse primer was designed using the Primer Express software ( Table 1 ). The only oligonucleotides that had to be created individually for every single patient were the upstream primers. For 22 patients (including cases 1-6 which for comparison were also analyzed with the 'ASO probe' RQ PCR approach) ASO upstream primers were designed using the sequence information of the IgH-CDR3 (N-D-N) junction.
RQ PCR
RQ PCR was performed in MicroAmp reaction tubes (PE Biosystems) on an ABI PRISM 7700 thermal cycler (PE Biosystems). Twenty-five l PCR mixture contained 12.5 l 2 × TaqMan Universal Mastermix (PE Biosystems), including AmpErase Uracil N-Glycosylase (UNG) and dUTP instead of dGTP as carry-over protection, 50-900 nM of each primer (assay-specific concentrations are shown in Table 2 ), 200 nM probe, sterile water (Merck, Darmstadt, Germany) and 1 g genomic DNA. Initial testings were done in 50 l final volumes. After two steps of 2 min at 50°C for UNG activation and 10 min at 95°C for AmpliTaq Gold activation DNA was subjected to 40 cycles of PCR with denaturation at 95°C for 15 s followed by a combined annealing/extension step at 59-65°C for 30 s (for assay-specific annealing/extension temperatures see Table 2 ).
Based on the 5Ј-3Ј exonuclease activity of Taq DNA polymerase double-labelled fluorogenic probes are cleaved during PCR. This results in a stepwise increase of reporter dye fluorescence due to increasing numbers of unquenched reporter molecules. Sequence detection software (SDS) (PE Biosystems) averages peak normalized reporter fluorescence intensity for each cycle and plots it vs cycle number. This allows calculation of a threshold cycle (C T ) defined as cycle number at which normalized reporter fluorescence (R N ) passes a fixed threshold baseline. For distinct amplification targets, the amount of target molecules in the reaction tube determines C T . Quantification results from comparison C T of the followup samples with a standard curve established by RQ PCR of serially diluted genomic DNA with known starting copy numbers. To generate a standard curve DNA from bone marrow (BM) samples at diagnosis with almost 100% tumor cell involvement were serially diluted in polyclonal DNA to give final concentrations of 10 , 10 −6 . After simultaneous amplification of standard dilution series and follow-up samples target copy numbers of follow-ups were related to the number of target copies at diagnosis. Experiments were done at least in triplicate. Standard dilution series also served as control for sensitivity of the assay. Sensitivity threshold was defined as last dilution with a specific fluorescence signal. Before starting quantitation we optimized each RQ PCR assay for the highest signal intensities and the lowest C T in testing different primer concentrations and annealing temperatures. To confirm DNA integrity and to normalize for differences in amount and quality of DNA samples the albumin gene was used as internal reference (primer/probe sequences are adopted from Pongers-Willemse et al 13 ) . Simultaneous albumin RQ PCR of polyclonal DNA serially diluted in water and undiluted patient DNA allowed comparison of amplifiable genomes per sample and subsequent normalization of MRD values.
Results and discussion
Diagnostic DNA samples of 22 patients with B-lineage ALL in which at least one clonally rearranged IgH-CDR3 allele could be detected by PCR were selected for study. Sequences of the Table 2 PCR conditions, utilized consensus oligonucleotides and sensitivites for RQ PCR assays using consensus probes. Allele-specific oligonucleotides (ASO) spanning the patient specific IgH-CDR3-region serve as upstream primers. ASO sequences are shown in clonotypic junctional regions are shown in Table 3 . To demonstrate the usefulness of the new real-time PCR assay, minimal residual disease was quantitated in follow-up samples of six patients (Figure 1 ).
Design of primers and probes for RQ PCR
Initially we used exclusively individually designed primer/probe sets (ASO probes in combination with ASO upstream primers and germline J H downstream primers) for Leukemia detection as described by Gerard et al 9 and Pongers-Willemse et al 13 ( Figure 1 ). ASO probes for six patients (cases 1-6) were designed using Primer Express software and according to the manufacturer's guidelines with respect to melting temperature, C/G ratio (Ͼ1), G/C content (Ͻ70%), avoidance of a 5ЈG and self-dimerization. Two probes had to be positioned on the antisense strand to fulfill PE Biosystem's recommendation of a C/G ratio greater than 1. With this approach, a detection limit of 5 × 10 −5 was reached in five cases and of 10 −3 in one case, which may not be sensitive enough for clinical application in ALL.
1,5,6,28,29 This problem has also been described in a recent paper by Pongers-Willemse et al, 13 who showed that this type of RQ PCR appeared to be comparable to quantification by dot-blotting but less sensitive than liquid hybridization. An additional disadvantage of this procedure is the expensive and time-consuming need for unique primer and probe sets for each individual patient.
In search of an improved IgH-RQ PCR assay, we therefore changed the method by creating probes and reverse downstream primers that anneal to conserved germline J H gene segments of the four most often rearranged J H families. As a consequence, solely the application of two probes and four reverse primers in combination with upstream ASO primers was sufficient to perform RQ PCR of about 90% of possible IgH rearrangements. One probe was complementary to a consensus area of the J families J H 1, J H 4 and J H 5 (probe J H Q 1/4/5 ) and one probe annealed to the joining region of the J H 6 family (probe J H Q 6 ). These J H probes were located on the sense strand just as the ASO primers to enhance assay's specificity by avoiding probe cleavage due to asymmetric amplification of germline IgH sequences. In addition, four different reverse primers were designed with support of Primer Express software that annealed to joining regions J H 1, J H 4, J H 5 and J H 6, respectively (Table 1) . For all patients it was possible to design allele-specific forward ASO primers that, in combination with suitable consensus probes and reverse primers, yielded specific RQ PCR results without background.
Optimization of the real-time PCR assay Reaction volume:
Initial tests were performed with 50 l of PCR mixture per tube following published RQ PCR protocols. 9, [11] [12] [13] [14] In order to save reagents and costs, we repeated the real-time PCR in 25 l reaction volumes leaving all concentrations unchanged except for DNA (1 g/tube). Neither peak normalized reporter fluorescence intensities nor threshold cycle numbers significantly changed and no loss of sensitivity was observed (Figure 2) . Consequently, we used 25 l reaction volumes in all further RQ PCR assays thereby saving about 50% of the reagent costs.
Cycling conditions:
PCR temperatures were determined according to the calculated primers' melting temperatures (T M ). If calculated T M values of both primers differed, optimal reaction conditions yielding highest ⌬R N (difference between R N and baseline fluorescence) and lowest C T with clonal samples were selected. Using these reaction conditions each RQ PCR with individual primer/probe sets resulted in clonespecific amplification in the absence of background fluorescence after 40 cycles of RQ PCR. With the consensus probe approach, annealing/extension temperatures had to be elevated to 61-65°C for cases 6, 9, 17 and 19 in order to avoid background (Table 2) . In case 11, the first designed ASO primer (5ЈATTGTAGTGGTGGTAGCTGCTATGAG3Ј) failed due to non-specific amplification. However, also in this case, specific amplicons were finally obtained when another upstream primer was located 11 bp further downstream and annealing/extension temperature was set at 65°C. This demonstrates, that the design of specific ASO primers and optimization of reaction temperatures are the critical steps when consensus germline probes are applied for RQ PCR, because germline probes are only specific for J H families and therefore Table 1 ). The arrows indicate probe position on the sense (୴) or antisense (୵) strand. IgH-CDR3 junctional sequences are deduced from PCR products (see Table 3 may also detect unrelated rearrangements using the corresponding J H .
Concentration of primers:
For further optimization, we tested different primer concentrations in reactions with 100 ng of clonal DNA. In most cases primer concentrations of 300 nM yielded the best results ( Table 2) .
Sensitivity of the RQ PCR assay with consensus J H probes
Utilizing these optimized conditions RQ PCR with consensus J H probes and 1 g of sample detected clonotypic cells with a sensitivity of at least 5 × 10 −5 (corresponding to 50 pg of clonal DNA or 7.5 copies) in 21 of 22 cases (95%) and 1 × 10 −4 in the remaining case with a dynamic range of at least four orders of magnitude (Table 2 ). Regression analysis of realtime data obtained from standard dilution series yielded r values у0.98 for copy numbers Ͼ15. When tumor levels р10 −4 were included in the analysis, r values were partly somewhat lower because of greater variation in C T at low copy numbers.
The method described here is as equally sensitive as traditional quantitative PCR assays.
1-3,5-7,28,30 Traditional quantitative PCR tests rely on end point data collection and are
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Figure 2
Comparison of IgH RQ PCR standard curves generated with 25 l () and 50 l () PCR mixture using serial dilutions of clonal DNA (case 22). Experiments were performed in triplicate. Threshold cycle numbers (C T ) (defined as cycle number at which normalized reporter fluorescence passes a fixed threshold baseline) were plotted against log 10 of target number for each assay and the plot was fitted with a least-squares regression equation. r, correlation coefficient. therefore susceptible to large variations in the amount of PCR product at a given target concentration due to many variables that determine the outcome of every single reaction. Methods that try to overcome these limitations by using multiple tube approaches 3, 7, 30, 31 or introducing internal standards 2, 22 are often difficult to standardize, require large amounts of DNA or are laborious to implement.
In contrast to previous PCR methods, real-time PCR assays measure PCR product during the exponential phase of PCR and eliminate the effect of limiting reagents. However, published methods targeting immune genes for RQ PCR 9, 13 require individual fluorogenic probes for each patient and are therefore labour intensive and expensive. Our modified realtime PCR assay solves this problem by using consensus probes and reaches at least the level of sensitivity as the method described by Pongers-Willemse et al 13 and Gerard et al. 9 
Clinical application of IgH CDR3-RQ PCR
The two different RQ PCR approaches described in this paper were applied to quantitate minimal residual disease in clinical follow-up samples of six patients (cases 1-6, Figure 1 ) at different time points during and after therapy. Standard dilution series and follow-up samples were examined at least in triplicate.
To normalize for differences in amount and quality of DNA during quantification of diagnostic and follow-up samples, albumin sequences were used as marker for a number of amplifiable genomes as described by Pongers-Willemse et al. 13 When 1 g of diagnostic DNA, based on optical density at 260 nm, was set as 100%, the estimated albumin copy numbers between equal amounts of different follow-up samples varied (data not shown). The greatest differences were seen in two of 17 follow-up samples where the estimated albumin copy numbers were 20-fold lower compared to equal amounts of DNA of the corresponding samples obtained at primary diagnosis. These two DNA samples were collected and stored 5 and 12 years before study and were obviously of low quality due to partial degradation. In general, variations in estimated copy numbers are probably the combined result of variations in integrity of DNA from different bone marrow samples due to storage conditions, DNA extraction and the presence of PCR inhibitors such as heparin and pipetting errors. This points out the enormous importance of confirmation of DNA integrity and amplification efficiency for exact MRD quantification. As demonstrated, renunciation of determination of amplifiable genomes can result in large quantification errors.
Normalized clone-specific RQ PCRs with the described consensus probe approach demonstrated a decrease of tumor load for all patients during treatment as shown in Figure 1 . Follow-ups of patients 1 and 2 who remained in complete remission were persistently PCR negative and therefore harbored tumor levels below the assays' detection limit. The first follow-up sample of patient 3 who also remained in complete clinical remission contained measurable low level MRD of 1.8 × 10 −5 ; two subsequent samples were PCR negative with a sensitivity of Ͻ1 × 10 . Patients 4, 5 and 6 relapsed after initial complete remission. In cases 4 and 6 increasing MRD levels preceeded clinical relapse for 3 and 11 months. For patient 5 the only material available before relapse was of low quality with only 5.8% of theoretical albumin copy numbers and was PCR negative at a detection limit of 5.2 × 10 −4 7 months prior to relapse (Figure 1) .
Comparison of consensus probes to patient-specific probes for real-time quantification
As shown in Figure 1 , sensitivity of the new RQ PCR system with ASO primers and consensus J H probes was moderately superior to the clone-specific primer/probe system in four of the six cases (cases 2-5). The most remarkable difference of the two RQ PCR approaches was seen in patient 6 with detection limits of 10 −3 for the ASO primer/probe system vs 10
for the new approach with the consensus probe. The estimated tumor load of the four follow-up samples that were MRD positive with both RQ PCR methods were higher in three cases (cases [3] [4] [5] when measured with the ASO probe approach and slightly lower in case 6. The ratios of the corresponding MRD values estimated with the two methods varied from 0.9 to 5.9 in individual samples. Taking into account that quantitative estimation of a single rearranged IgH allele in a dominant polyclonal background is much more complex than quantification of single copy genes, this moderate variation between two different PCR approaches should be tolerated.
Concordance in MRD status was demonstrated with both approaches for five of the six patients whereas maximum possible MRD levels in PCR-negative samples differed due to differing sensitivity limits. In case 6 an increasing MRD level as indicator for subsequent clinical relapse was detected 44 weeks earlier with the 'consensus' RQ PCR (Figure 1 ).
In conclusion, this study demonstrates that the novel realtime PCR assay using consensus probes in combination with an ASO primer for detection of clonally rearranged IgH sequences is sensitive, specific and easy to perform. It simplifies current approaches for detection of MRD in B-lymphoid malignancies and will allow analysis of large numbers of patient samples in clinical trials with reasonable costs, relatively low time consumption, and a high level of sensitivity. Furthermore, this technique should also be applicable for realtime quantitative PCR using rearranged TCR␤, TCR␥ and TCR␦ regions.
